Tumor Immune Microenvironment Heterogeneity and Key Immunoregulatory Gene Expression in Lung Cancer
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/8365959 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 02.11.2026. Verfasst von Jianghua Mao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology People's Hospital of Chongqing Liangping District Chongqing China. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim of this study is to characterize the cellular heterogeneity and key immunoregulatory gene expression patterns of the tumor immune microenvironment (TIME) in lung cancer using single‐cell RNA sequencing (scRNA‐seq).
Methods
The scRNA‐seq dataset GSM4453577 was retrieved from NCBI GEO. Unsupervised clustering, cell–cell communication analysis, pseudotime trajectory reconstruction, and GO/KEGG enrichment analyses were performed.
Results
Seven immune cell types were annotated from 223 single cells after quality control. Macrophages demonstrated the strongest outgoing intercellular interaction intensity and showed relatively high SPP1‐associated expression‐based interaction scores, with macrophages and monocytes identified as the dominant SPP1 signal sources. ISG15 showed the broadest expression across all seven immune cell types (highest z‐scores in stem‐like/mast cells and neutrophils), whereas TNFRSF18 and TNFRSF4 exhibited similar descriptive expression trends during intermediate pseudotime stages (scaled 0–1), with TNFRSF18 enriched in stem‐like/mast cells ( z = 1.93) and TNFRSF4 in mast cells ( z = 2.22). T cell, NK cell, and Treg markers (CD3E, NKG7, and FOXP3) were below the detection threshold, consistent with the predominantly myeloid/B‐lineage immune infiltrate in this sample.
Conclusion
ScRNA‐seq analysis of a single GEO sample (GSM4453577; 223 cells; PC1 explaining 5.3% of variance) suggested myeloid/B‐lineage immune cell heterogeneity in the lung cancer microenvironment and identified ISG15, TNFRSF18, and TNFRSF4 as candidates of potential immunoregulatory interest; external multisample validation is required before generalizing these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology People's Hospital of Chongqing Liangping District Chongqing China.
ORCID-Profile: Jianghua Mao, Xue Zhang, Rongwei Yang, Xiaolin Wang
Zitieren
APA
Mao, J., Zhang, X., Yang, R., & Wang, X. (2026). Tumor Immune Microenvironment Heterogeneity and Key Immunoregulatory Gene Expression in Lung Cancer. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/8365959
Vancouver
Mao J, Zhang X, Yang R, Wang X. Tumor Immune Microenvironment Heterogeneity and Key Immunoregulatory Gene Expression in Lung Cancer. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/8365959
BibTeX
@article{Mao2026,
author = {Mao, Jianghua and Zhang, Xue and Yang, Rongwei and Wang, Xiaolin},
title = {Tumor Immune Microenvironment Heterogeneity and Key Immunoregulatory Gene Expression in Lung Cancer},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/8365959}
}
EUVIMED